Current Search Criteria: Intervention: docetaxel, oxaliplatin, 5-FU, leucovorin
Found 79 matching trials
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma PHASE2 This study is a prospective, single arm, multi-center phase II clinical tri...
Show More Location
The First Affiliated Hospital, College of Medicine, Zhejiang University
Learn More & Join Trial
HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT) PHASE3 This is a multicenter, randomized, controlled, open-label study evaluating ...
Show More Location
Uniklinik RWTH Aachen, AöR, Medizinische Klinik III, Studienzentrum Viszeralmedizin
Learn More & Join Trial
5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer PHASE2 Patients with locally advanced resectable adenocarcinoma of the stomach or ...
Show More Location
Krankenhaus Nordwest
Learn More & Join Trial
Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG PHASE2 IMAGINE is a Phase II, randomized, two-arm, chemotherapy controlled modular...
Show More Learn More & Join Trial
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors PHASE1 This is a first-in-human (FIH), open-label, and multi-center Phase I/II stu...
Show More Location
START Los Angeles, LLC
Learn More & Join Trial
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors PHASE1 Immune therapies work with the body's immune system to treat a number of ca...
Show More Location
Providence Medical Foundation
Learn More & Join Trial
Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer PHASE2 Concurrent chemoradiotherapy has been demonstrated a significant improvemen...
Show More Location
Zhongnan Hospital of Wuhan University
Learn More & Join Trial
Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative Treatment PHASE1 This is an open-label,multi-centre, phase 1b safety and feasibility study a...
Show More Location
Multiple Locations
Learn More & Join Trial
An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma PHASE2 This study is to evaluate the effectiveness of treatment for esophagogastri...
Show More Location
National Cancer Center Hospital East
Learn More & Join Trial
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) PHASE1 To evaluate the safety and tolerability of sotorasib administered in invest...
Show More Status
Active Not Recruiting
Location
Arizona Oncology Associates Professional Corporation
Learn More & Join Trial